Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer

Open access
Chen, Feng, Ma, Kai, Madajewski, Brian, Zhuang, Li, Zhang, Li, Rickert, Keith, Marelli, Marcello, Yoo, Barney, Turker, Melik Z., Overholtzer, Michael, Quinn, Thomas P., Gonen, Mithat, Zanzonico, Pat, Tuesca, Anthony, Bowen, Michael A., Norton, Larry, Subramony, J. Anand, Wiesner, Ulrich, Bradbury, Michelle S. · 2018 · Nature Communications

Abstract

Controlling the biodistribution of nanoparticles upon intravenous injection is the key to achieving target specificity. One of the impediments in nanoparticle-based tumor targeting is the inability to limit the trafficking of nanoparticles to liver and other organs leading to smaller accumulated amounts in tumor tissues, particularly via passive targeting. Here we overcome both these challenges by designing nanoparticles that combine the specificity of antibodies with favorable particle biodistribution profiles, while not exceeding the threshold for renal filtration as a combined vehicle. To that end, ultrasmall silica nanoparticles are functionalized with anti-human epidermal growth factor receptor 2 (HER2) single-chain variable fragments to exhibit high tumor-targeting efficiency and efficient renal clearance. This ultrasmall targeted nanotheranostics/nanotherapeutic platform has broad utility, both for imaging a variety of tumor tissues by suitably adopting the targeting fragment and as a potentially useful drug delivery vehicle.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-06271-5

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 185

Metadata

Authors
Chen, F., Ma, K., Madajewski, B., Zhuang, L., Zhang, L., Rickert, K., Marelli, M., Yoo, B., Turker, M. Z., Overholtzer, M., Quinn, T. P., Gonen, M., Zanzonico, P., Tuesca, A., Bowen, M. A., Norton, L., Subramony, J. A., Wiesner, U., & Bradbury, M. S.
Venue
Nature Communications
Published
2018-10-08
Volume
9
Issue
1
Pages
4141-4141
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2894805846
Cited by
185
References
3
FWCI
6.75
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer. https://app.cochat.ai/papers/10.1038/s41467-018-06271-5
The paper
Chen, F., Ma, K., Madajewski, B., Zhuang, L., Zhang, L., Rickert, K., Marelli, M., Yoo, B., Turker, M. Z., Overholtzer, M., Quinn, T. P., Gonen, M., Zanzonico, P., Tuesca, A., Bowen, M. A., Norton, L., Subramony, J. A., Wiesner, U., & Bradbury, M. S. (2018). Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer. Nature Communications. https://doi.org/10.1038/s41467-018-06271-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.